Study on personalized radiation for untreated liver tumors
Part of Cancer, Digestive system clinical trials.
This study checks how well a custom radiation treatment plan works for people with a single liver tumor (HCC) that hasn't been treated before. TheraSphere uses tiny beads with radiation to target the tumor while sparing healthy liver.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a single liver tumor that cannot be removed with surgery.
- You have not had any previous treatment for this liver cancer.
- You are able to care for yourself and do most daily activities (ECOG 0 or 1).
- Your liver, kidneys, and blood counts are working well enough.
- You do not have cancer spread outside the liver or major blood vessel involvement.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a targeted internal radiation treatment for people with liver cancer (HCC) that is too widespread for surgery and goes beyond the up-to-7 criteria. It aims to see if this therapy can safely and effectively treat tumors that are all located in a specific area of the liver.
This trial tests if a targeted radiation treatment, called SIRT, can shrink liver tumors enough to allow for a liver transplant or surgical removal. It is for people with liver cancer who are not yet eligible for these procedures.
This trial is testing a low 'scout' dose of tiny radioactive beads (resin microspheres) given into the liver to treat liver cancer. The goal is to see if this approach is safe and helps patients with certain types of liver cancer that cannot be surgically removed.
This trial tests two different ways to treat liver cancer that can't be removed with surgery. It compares stereotactic body radiation therapy (targeted high-dose radiation) with selective internal radiation therapy (tiny radioactive beads delivered through a blood vessel), both combined with immunotherapy (medicines that help your immune system fight cancer).
This trial tests a treatment called TheraSphere for people with liver cancer that hasn't responded to standard care or can't have it. TheraSphere uses tiny radioactive beads to target tumors in the liver, and this study is being done to get it approved in Japan.
This trial tests an affordable, Indian-made treatment for liver cancer (HCC) that can't be surgically removed. Tiny beads (microspheres) are injected into the liver's blood supply to directly deliver radiation to the tumor, potentially shrinking it and slowing the cancer.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.